Amyotrophic Lateral Sclerosis
Clinical research in amyotrophic lateral sclerosis focuses on slowing disease progression and preserving motor function in ambulatory patients, with attention to symptom burden and functional decline.
- ALS Functional Rating Scale-Revised
- Neuroprotection
- Motor neuron disease
The therapeutic interest in this area centers on combination approaches and supportive treatment strategies relevant to neuromuscular degeneration.
Hepatorenal Polycystic Diseases
Research activity in hepatorenal polycystic diseases addresses cyst growth control and disease progression in patients with polycystic liver involvement, alongside broader interest in inherited cystic disorders.
- Polycystic liver disease
- Total liver cyst volume
- Genetic biomarkers
Work in this field is linked to hepatology, nephrology, and biomarker-oriented clinical assessment.
Hip Fracture
Clinical studies in hip fracture concentrate on reducing perioperative blood loss and limiting the need for transfusion in hospitalised patients.
- Blood conservation
- Perioperative care
- Transfusion reduction
This area reflects interest in orthopaedic trauma and surgical support therapies that improve acute fracture management.
